Preventive online and offline health management intervention in polycystic ovary syndrome
Open accessAbstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, hyperinsulinemia, ovarian polycystic changes, and irregular ovulation, often occurring in women of childbearing age for whom it can be a cause of infertility. Hypothalamus-pituitary-ovarian axis dysregulation is important in the pathogenesis of PCOS and the associated chronic excess of sex hormones can lead to cardiovascular and cerebrovascular diseases, diabetes, and malignancies such as endometrial cancer, and breast cancer. At present, most scholars agree that lifestyle interventions in conjunction with drug treatment can help PCOS patients achieve their goals of successful pregnancy and childbirth. AIM: To investigate the clinical effect of an online and offline (O2O) preventive health management model on PCOS with kidney deficiency and phlegm dampness. METHODS: A total of 82 patients with PCOS of the kidney deficiency and phlegm dampness type who were admitted to Beijing Luhe Hospital Affiliated to Capital Medical University from April 2019 to June 2020 were randomly divided into two groups. The treatment group was treated with oral Diane-35 for 3 mo and received preventive O2O medical health management for 6 mo (including eating and living, exercise, drug management). The control group was treated with oral Diane-35 for 3 mo and completed outpatient health education. The traditional Chinese medicine (TCM) syndrome score, acne score, hair score, sex hormone level and clinical effects were compared between the two groups before and after the intervention. RESULTS: < 0.05). CONCLUSION: An integrated therapeutic approach incorporating medication, TCM methods and social media is more effective than standard treatment for PCOS.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A 2022 study conducted in China using the Mint Health app also used WeChat to educate patients on PCOS and support them with self-management methods, encouraging them to be more actively involved in treatment decisions and interventions.
“A 2022 study conducted in China using the Mint Health app also used WeChat to educate patients on PCOS and support them with self-management methods, encouraging them to be more actively involved in treatment decisions and interventions [60].”
From Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review (2024) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Pundir, J., Psaroudakis, D., Savnur, P., Bhide, P., Sabatini, L., Teede, H., Coomarasamy, A., & Thangaratinam, S. (2018) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14754 · Cited by 115 · see citing works
Forslund, M., Landin‐Wilhelmsen, K., Schmidt, J., Brännström, M., Trimpou, P., & Dahlgren, E. (2019) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13489 · Cited by 60 · see citing works
Flagged first, then by citations
Research works printed but not linked: 18
- [1]Jin P Xie Y Treatment strategies for women with polycystic ovary syndrome Gynecol Endocrinol 2018 34 272 277 29084464
- [2]Wang B Yan W Hou LH Wu XK [Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome] Zhong Xi Yi Jie He Xue Bao 2010 8 1018 1022 21078264
- [3]Wang Y Zhao Y Yu S Hu Y [Some issues from Effect of acupuncture and clomiphene in Chinese women with polycystic ovary syndrome in JAMA] Zhongguo Zhen Jiu 2017 37 1342 1346 29355003
- [4]Ma K [Advantages of integrated Chinese and western medicine in diagnosis and treatment of anovulatory infertility due to kidney deficiency and blood stasis] Zhongguo Zhong Yao Za Zhi 2021 46 2623 2628 34296556
- [5]Wang XJ [The Chinese medicine syndrome typing mode at the same level is the key point to explore the syndrome laws of disease. An inspiration from studying Chinese medicine syndrome laws of polycystic ovarian syndrome] Zhongguo Zhong Xi Yi Jie He Za Zhi 2012 32 1413 1415 23163158
- [6]Jin C Pang R Xu L Wu Z Zhao J [Clinical rules for acupoint selection and prescription composition in treatment of polycystic ovary syndrome with acupuncture] Zhongguo Zhen Jiu 2015 35 625 630 26480575
- [7]Ma K Li M [Study on the mechanism of Bushen Culuan Chongji treating "kidney deficiency and blood stasis" in ovulatory dysfunctional infertility] Zhongguo Zhong Yao Za Zhi 2017 42 4445 4450 29376235
- [8]Li M Ma K Shan J [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis] Zhongguo Zhong Yao Za Zhi 2014 39 3860 3864 25612455
- [9]Peigné M Villers-Capelle A Robin G Dewailly D [Hyperandrogenism in women] Presse Med 2013 42 1487 1499 24184282
- [10]Lima PDA Nivet AL Wang Q Chen YA Leader A Cheung A Tzeng CR Tsang BK Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages Biol Reprod 2018 99 838 852 29688269 PMC6203875
- [11]Puttabyatappa M Padmanabhan V Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome J Mol Endocrinol 2018 61 R161 R184 29941488 PMC6192837
- [12]Santos Simões R Carbonel AAF Borges FT Baracat MCP da Silva Sasso GR Simões MJ Serafini PC Soares JM Júnior Nader HB Baracat EC Analysis of hyaluronic acid in the endometrium of women with polycystic ovary syndrome Gynecol Endocrinol 2019 35 133 137 30614308
- [14]Kowalczyk K Franik G Kowalczyk D Pluta D Blukacz Ł Madej P Thyroid disorders in polycystic ovary syndrome Eur Rev Med Pharmacol Sci 2017 21 346 360 28165551
- [16]Kokanalı D Karaca M Ozakşit G Elmas B Engin Üstün Y Serum Vitamin D Levels in Fertile and Infertile Women with Polycystic Ovary Syndrome Geburtshilfe Frauenheilkd 2019 79 510 516 31148851 PMC6529227
- [17]Bicer M Alan M Alarslan P Guler A Kocabas GU Imamoglu C Aksit M Bozkaya G Isil AM Baloglu A Aslanipoiur B Calan M Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndrome J Endocrinol Invest 2019 42 303 312 29956214
- [18]Alur-Gupta S Dokras A Polycystic ovary syndrome: is the cardiometabolic risk increased after menopause? Menopause 2019 26 331 333 30649087
- [19]Rubin KH Andersen MS Abrahamsen B Glintborg D Socioeconomic status in Danish women with polycystic ovary syndrome: A register-based cohort study Acta Obstet Gynecol Scand 2019 98 440 450 30516823
- [20]Jafari Khorchani M Zal F Neisy A The phytoestrogen, quercetin, in serum, uterus and ovary as a potential treatment for dehydroepiandrosterone-induced polycystic ovary syndrome in the rat Reprod Fertil Dev 2020 32 313 321 31661670
Cited by
Sorted by citations
Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review
Graca, S., Alloh, F., Lagojda, L., Dallaway, A., Kyrou, I., Randeva, H. S., & Kite, C. (2024) · Healthcare · doi:10.3390/healthcare12161671 · Cited by 14 · see citing works
“The final study, which looked at the context of comments (n = 85,872) posted on YouTube videos about PCOS (n = 940) across 12 years, found that, where it was possible to identify gender (n = 13,106), 88.5% of those comments (n = 11,601) were posted by female users [72].”
BackgroundInfluential
- Authors
- Liu, R., Li, M., Wang, P., Yu, M., Wang, Z., & Zhang, G.-Z.
- Affiliations
- Capital Medical University (CN)
- Venue
- World Journal of Clinical Cases
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2022-04-06
- Volume
- 10
- Issue
- 10
- Pages
- 3060-3068
- ISSN
- 2307-8960 (ISSN-L)
- PMC
- PMC9082701
- OpenAlex
- W4220885045
- Cited by
- 7
- References
- 2
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 2
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Clinical Cases (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Complementary and alternative medicine › Traditional Chinese Medicine Studies
- Keywords
- polycystic ovary syndrome, preventive health measures, traditional Chinese medicine syndrome, Diane-35, acne, hirsutism, sex hormone levels, lifestyle intervention, social media health education
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review